OACC

Oaktree Acquisition Corp. III Life Sciences is a shell company operating in the Financial Services sector and Shell Companies industry. Its market capitalization stands at $260.49 million. The financial health of Oaktree Acquisition Corp. III Life Sciences is marked by minimal profitability, with gross margin, operating margin, and profit margin all at 0.0%. The net income for the trailing twelve months (TTM) amounts to $2.66 million. On its balance sheet, the company has cash reserves of $1.33 million and debt totaling $11,824. The valuation context is characterized by a negative price-to-book ratio of -38.53. Other key metrics such as P/E ratio, forward P/E, price-to-sales, EV/EBITDA, revenue growth (YoY), earnings growth (YoY), dividend yield, and payout ratio are not available or calculated for the company. The current ratio is 2.14.